Inventor
XIAO LEI
CN123 patents
⚠️ This page may combine multiple inventors who share the name “XIAO LEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
QUALCOMM INC
11 patentsUS9872242B2Jan 16, 2018
Joint transmission of CSI-RS for channel state feedback and transmission point selection
QUALCOMM INC11 citations84
US12375322B2Jul 29, 2025
Antenna element calibration algorithm
QUALCOMM INC2 citations75
US11863494B2Jan 2, 2024
User equipment override for enhanced type-II channel state information
QUALCOMM INC3 citations75
US10313167B2Jun 4, 2019
Phase rotation for in-band signal generation for narrow band transmission
QUALCOMM INC2 citations73
US9178562B2Nov 3, 2015
Method and apparatus to dynamically select UE processing capabilities based on channel impulse response estimates
QUALCOMM INC5 citations72
US12302158B2May 13, 2025
Spatial metric based mobility procedures using multi-port mobility reference signals
QUALCOMM INC1 citations64
US12316575B2May 27, 2025
CPU, resource, and port occupation for multi-TRP CSI
QUALCOMM INC0 citations63
US11916609B2Feb 27, 2024
Techniques for indicating a user equipment capability for Layer 1 signal to interference plus noise ratio measurement
QUALCOMM INC0 citations63
US11424790B2Aug 23, 2022
Techniques for frequency domain restriction for channel state information with frequency domain compression
QUALCOMM INC0 citations63
US11057250B2Jul 6, 2021
Phase rotation for in-band signal generation for narrow band transmission
QUALCOMM INC0 citations63
US11881924B2Jan 23, 2024
Beam selection for receiving channel state information reference signals for layer 3 measurement
QUALCOMM INC0 citations62
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD
9 patentsUS11104732B2Aug 31, 2021
Reducing immune inhibition induced by SIGLEC-15
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD6 citations83
US11008556B2May 18, 2021
Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cells
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD2 citations72
US11690874B2Jul 4, 2023
Use of chimeric antigen receptor modified cells to treat autoimmune disease
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD2 citations70
US12297267B2May 13, 2025
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US12240915B2Mar 4, 2025
Chimeric antigen receptor cells for treating solid tumor
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US12150960B2Nov 26, 2024
Modified cell expansion and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US12076343B2Sep 3, 2024
Engineered safety in cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11834502B2Dec 5, 2023
Reducing immune inhibition induced by SIGLEC-15
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
US11739136B2Aug 29, 2023
Inducible dominant negative PD-1 and uses in adoptive cell therapy
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD0 citations62
INNOVATIVE CELLULAR THERAPEUTICS CO LTD
8 patentsUS9932405B2Apr 3, 2018
Use of chimeric antigen receptor modified cells to treat cancer
INNOVATIVE CELLULAR THERAPEUTICS CO LTD13 citations91
US10561686B2Feb 18, 2020
Modified cell expansion and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS CO LTD17 citations85
US10493139B2Dec 3, 2019
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
INNOVATIVE CELLULAR THERAPEUTICS CO LTD9 citations84
US10869888B2Dec 22, 2020
Modified cell expansion and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS CO LTD10 citations83
US10918667B2Feb 16, 2021
Modified cell expressing therapeutic agent and uses thereof
INNOVATIVE CELLULAR THERAPEUTICS CO LTD2 citations72
US10793638B2Oct 6, 2020
Use of chimeric antigen receptor modified cells to treat cancer
INNOVATIVE CELLULAR THERAPEUTICS CO LTD2 citations71
US11981920B2May 14, 2024
Modified cell with enhanced migration capability
INNOVATIVE CELLULAR THERAPEUTICS CO LTD0 citations62
US11866494B2Jan 9, 2024
CAR T therapy through uses of co-stimulation
INNOVATIVE CELLULAR THERAPEUTICS CO LTD0 citations62
FACEBOOK TECH LLC
4 patentsUS10664953B1May 26, 2020
Systems and methods for generating defocus blur effects
FACEBOOK TECH LLC42 citations97
US11094075B1Aug 17, 2021
Systems and methods utilizing a machine learning model for generating defocus blur effects
FACEBOOK TECH LLC12 citations85
US11367165B2Jun 21, 2022
Neural super-sampling for real-time rendering
FACEBOOK TECH LLC8 citations84
US11150605B1Oct 19, 2021
Systems and methods for generating holograms using deep learning
FACEBOOK TECH LLC18 citations82
TENCENT TECH SHENZHEN CO LTD
2 patentsUS9607355B2Mar 28, 2017
Model parallel processing method and apparatus based on multiple graphic processing units
TENCENT TECH SHENZHEN CO LTD26 citations93
US10282809B2May 7, 2019
Data parallel processing method and apparatus based on multiple graphic processing units
TENCENT TECH SHENZHEN CO LTD7 citations82
HORN GAVIN B
1 patentFACEBOOK TECHNOLOGIES LLC
1 patentCRRC ZHUZHOU ELECTRIC LOCOMOTIVE RES INSTITUTE CO LTD
1 patentLIFE SAFETY DISTRIB GMBH
1 patentXIAO LEI
1 patentPALANKI RAVI
1 patentVMWARE INC
1 patentUNIV TSINGHUA
1 patentMETA PLATFORMS TECH LLC
1 patentERICSSON TELEFON AB L M
1 patentHONEYWELL INT INC
1 patentCSR ZHUZHOU ELECTRIC LOCOMOTIVE RES INSTITUTE CO LTD
1 patentHUAWEI TECH CO LTD
1 patentKYLAND TECHNOLOGY CO LTD
1 patentHAN'S LASER TECH IND GROUP CO LTD
1 patentWONDERLAND SWITZERLAND AG
1 patentShowing the top 50 of 123 patents by PatentIndex Score.